Amalgamated Financial’s DexCom DXCM Stock Holding History

Amalgamated Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$13.1M	Buy	+102,612	New	+$11.2M	0.1%	149

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amalgamated Financial's DXCM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in DexCom (DXCM) in Q1 2022: 102,612 shares worth $13.1M. The stake represents 0.1% of the portfolio and ranks #149 among its holdings.

862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Amalgamated Financial held 102,612 shares of DexCom worth $13.1M as of Q1 2022.
DexCom was a new Amalgamated Financial position in Q1 2022.
DexCom made up 0.1% of Amalgamated Financial's portfolio in Q1 2022, its #149 holding.
862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.